Adiponectin inhibits lipopolysaccharide-induced adventitial fibroblast migration and transition to myofibroblasts via AdipoR1-AMPK-iNOS pathway. - Wikidata - awgldk - TriplyDB

Adiponectin inhibits lipopolysaccharide-induced adventitial fibroblast migration and transition to myofibroblasts via AdipoR1-AMPK-iNOS pathway.

Adiponectin inhibits lipopolysaccharide-induced adventitial fibroblast migration and transition to myofibroblasts via AdipoR1-AMPK-iNOS pathway.

http://www.wikidata.org/entity/Q33670461

about

Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability N-acetylcysteine and allopurinol synergistically enhance cardiac adiponectin content and reduce myocardial reperfusion injury in diabetic rats AMPK activity regulates trafficking of mitochondria to the leading edge during cell migration and matrix invasion.Adiponectin upregulates prolyl-4-hydroxylase α1 expression in interleukin 6-stimulated human aortic smooth muscle cells by regulating ERK 1/2 and Sp1.Interactions of adiponectin and lipopolysaccharide from Porphyromonas gingivalis on human oral epithelial cells.Lipopolysaccharide induces lung fibroblast proliferation through Toll-like receptor 4 signaling and the phosphoinositide3-kinase-Akt pathway Development of second generation peptides modulating cellular adiponectin receptor responses.Emerging role of adipokines as mediators in atherosclerosis.Adiponectin reduces carotid atherosclerotic plaque formation in ApoE-/- mice: roles of oxidative and nitrosative stress and inducible nitric oxide synthase.Activation of AMP-activated protein kinase is essential for lysophosphatidic acid-induced cell migration in ovarian cancer cells.Temporal and Molecular Analyses of Cardiac Extracellular Matrix Remodeling following Pressure Overload in Adiponectin Deficient Mice AMPK Signaling Involvement for the Repression of the IL-1β-Induced Group IIA Secretory Phospholipase A2 Expression in VSMCs.Effects of basal insulin application on serum visfatin and adiponectin levels in type 2 diabetes.Adiponectin action: a combination of endocrine and autocrine/paracrine effects.Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities.The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy.Epigenetic regulation of Thy-1 gene expression by histone modification is involved in lipopolysaccharide-induced lung fibroblast proliferation.Perivascular fat, AMP-activated protein kinase and vascular diseases.Resveratrol inhibits adventitial fibroblast proliferation and induces cell apoptosis through the SIRT1 pathway Adiponectin: mechanisms and new therapeutic approaches for restoring diabetic heart sensitivity to ischemic post-conditioning.Adipokines, vascular wall, and cardiovascular disease: a focused overview of the role of adipokines in the pathophysiology of cardiovascular disease.Melatonin inhibits visfatin-induced inducible nitric oxide synthase expression and nitric oxide production in macrophages.Azithromycin may inhibit interleukin-8 through suppression of Rac1 and a nuclear factor-kappa B pathway in KB cells stimulated with lipopolysaccharide.Hypoxia-Induced Upregulation of miR-132 Promotes Schwann Cell Migration After Sciatic Nerve Injury by Targeting PRKAG3.Soluble Epoxide Hydrolase Inhibition Protected against Angiotensin II-induced Adventitial Remodeling Adiponectin Is Involved in Connective Tissue Growth Factor-Induced Proliferation, Migration and Overproduction of the Extracellular Matrix in Keloid Fibroblasts.Chondrocyte AMP-activated protein kinase activity suppresses matrix degradation responses to proinflammatory cytokines interleukin-1β and tumor necrosis factor α.Adiponectin controls the apoptosis and the expression of tight junction proteins in brain endothelial cells through AdipoR1 under beta amyloid toxicity.Globular Adiponectin Limits Microglia Pro-Inflammatory Phenotype through an AdipoR1/NF-κB Signaling Pathway.Chikusetsu Saponin IVa Ameliorates Cerebral Ischemia Reperfusion Injury in Diabetic Mice via Adiponectin-Mediated AMPK/GSK-3β Pathway In Vivo and In Vitro.Fatty liver index, gamma-glutamyltransferase, and early carotid plaques.FAK activity is required for HGF to suppress TGF-β1-induced cellular proliferation.

P2860

Q26825697-16EDFDFD-D69D-4263-80B3-16FFD1A20729 Q27313607-E4FEB9C8-CC7A-4AA2-A13B-DE8E28739139 Q28476775-83324A8E-2BB5-45C0-9D17-9D3ECE643468 Q30806095-3BE8D667-98EC-4317-A099-FE22AA875793 Q33987936-43DEBA43-2020-45F3-A2AD-DE6CEA118577 Q34154641-3248300F-85F7-472B-B1F2-83B7B4854DE1 Q34259817-3798E059-A19F-434A-9046-EB82E5D276E6 Q34360125-412824B7-1400-41AC-AEEF-CD7B4DCB8A62 Q34427067-37A54EDC-5994-4F3F-A527-9CE96371F52E Q34731260-743EBC5A-B652-4DCB-B4DB-B870117CE64B Q35085076-6CB210E9-4592-4AB9-A7FC-2A12E7A21F7D Q35614083-8B8C046E-5056-43DC-9999-F0A90A44A41E Q35688331-3706148A-DC52-44CB-91D8-17563522DD95 Q35758165-6EEE45F5-F399-4008-B1ED-114475CB205B Q35971216-DFEF8B97-074A-4420-9C51-91CD3DFB3527 Q36479405-189D241B-9614-4EFF-942B-006D07A47BE9 Q36633255-BF2BC19E-16EB-4B23-AC2B-49DD97FFBC05 Q37295341-273A68BD-2FC6-46C4-BE8E-05F6F999D434 Q37671282-19ADE181-2AFA-42CB-97F1-F8E77D01C61F Q37720061-717FA18F-A408-40CD-A71B-265DBCD8EF62 Q38125624-C0CFA7D2-C097-40FC-A338-F25DD0682E76 Q38188874-70DF63AC-4475-4D25-A60C-3E3565AD91F5 Q39123521-763AD90E-C6E9-4707-BE2F-4C02B8DFEAA5 Q39574149-6E293FA2-A34A-4AFE-AD7E-ACFA1D3EBD1D Q40509533-C1A72E16-79A6-411E-81E3-3950FB51C3FF Q41191530-7688BA6A-DAA8-407A-8C89-B384AA5E3B48 Q42229072-0155133D-01AB-4875-8399-333CA1357448 Q42783350-42DFF353-68C5-4BB9-9F6E-AE51A0D664AD Q46288375-79C45A24-5C25-4A7B-8517-709CC7CBD27A Q47096780-ACF0CCED-96FD-40EB-946B-4DCA952C588D Q48352610-3606BF54-F05C-45D5-88E2-5722D8173880 Q51423127-0762FF66-B7DB-42AF-B44E-DE6366F441F4 Q53535048-3B65ECDE-C2F5-4970-B5B1-FE868C7636E4

P2860

Adiponectin inhibits lipopolysaccharide-induced adventitial fibroblast migration and transition to myofibroblasts via AdipoR1-AMPK-iNOS pathway.

http://www.wikidata.org/entity/Q33670461

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Adiponectin inhibits lipopolys ...... via AdipoR1-AMPK-iNOS pathway.

@ast

Adiponectin inhibits lipopolys ...... via AdipoR1-AMPK-iNOS pathway.

@en

type

label

Adiponectin inhibits lipopolys ...... via AdipoR1-AMPK-iNOS pathway.

@ast

Adiponectin inhibits lipopolys ...... via AdipoR1-AMPK-iNOS pathway.

@en

prefLabel

Adiponectin inhibits lipopolys ...... via AdipoR1-AMPK-iNOS pathway.

@ast

Adiponectin inhibits lipopolys ...... via AdipoR1-AMPK-iNOS pathway.

@en

P1433

Q33670461-A66630EE-357C-4E85-AAD4-D9D3FF955BCB

P1476

Q33670461-15F3DCB1-7897-498C-AD83-97B1B71BB7F1

P2093

Q33670461-49BAFD65-A72B-4583-A845-B79EF2BA5D07

Q33670461-54A951FA-D9F6-405A-B489-FC5BF7DA8FE4

Q33670461-613722C5-A98A-4ABD-AAC5-9A535597C069

Q33670461-6AE48EC3-F68C-4771-94F1-900351D18076

Q33670461-6F29B913-B3A5-416B-BE96-3986F08BCFA3

Q33670461-8C08D722-C605-417B-BA8E-BF6A5956872F

Q33670461-A8068708-8FDF-432D-B05D-C3ECAEAE7301

Q33670461-CBB7A1E0-FC0A-4899-8AE3-66E3317B21BB

Q33670461-CE70F3EB-2CEA-48B0-962C-3A078E1A5507

Q33670461-CEA9D3D5-1CB4-421B-8150-3EF4D39CC671

P2860

Q33670461-032C897A-3631-48BB-BDE9-D141241FEF86

Q33670461-0BB19B54-B6F6-45EC-B61C-AE3E8D019534

Q33670461-149A2239-BA10-4C7A-83D7-7534772BCCB6

Q33670461-15B1AB3D-6615-4F9D-AE1E-B38517B522B0

Q33670461-18D8915E-1B42-479B-B3ED-36CE3D428D01

Q33670461-273CE6BC-C86F-4C89-8376-66755A1AD5E7

Q33670461-3B0DAB4E-989E-4798-A654-A0CEDA6AD152

Q33670461-512DE140-FF34-4737-BEFC-509C68B82472

Q33670461-56FC3A78-36DF-42D9-A2FC-66FB51867641

Q33670461-5D31330C-AAC9-4881-BC53-236DDFF6543F

P304

Q33670461-3F88E272-4D34-4B94-B761-6F693008BF9E

P31

Q33670461-3EE6FCF0-2D73-4078-AF10-E8FE605806FE

P356

Q33670461-C38675DD-1630-4369-8504-D18A4E23E74E

P433

Q33670461-D1CE2C67-27E0-4A17-9E81-77EFA5F1C243

P478

Q33670461-11E4197D-C36C-48AC-8DD0-65E4AD3A247C

P577

Q33670461-9CE028F7-3844-48EF-9F8C-D8AEC92ED01C

P698

Q33670461-694108F1-CFA8-4DD5-8097-6224F8FAAC09

P921

Q33670461-FE52544F-FC8F-4FDE-B76A-A59B00BDA655

P932

Q33670461-A6CF006B-6A96-407B-865B-9355E95C44D0

P356

P1433

Molecular Endocrinology

P1476

Adiponectin inhibits lipopolys ...... via AdipoR1-AMPK-iNOS pathway.

@en

P2093

Ke Zhang

http://www.w3.org/2001/XMLSchema#string

Li Li

http://www.w3.org/2001/XMLSchema#string

Liang Chen

http://www.w3.org/2001/XMLSchema#string

Mei Zhang

http://www.w3.org/2001/XMLSchema#string

Min Feng

http://www.w3.org/2001/XMLSchema#string

Ming-xiang Zhang

http://www.w3.org/2001/XMLSchema#string

Xiao-bo Hu

http://www.w3.org/2001/XMLSchema#string

Xiao-jun Cai

http://www.w3.org/2001/XMLSchema#string

Xuan Li

http://www.w3.org/2001/XMLSchema#string

Yuan-yuan Rong

http://www.w3.org/2001/XMLSchema#string

P2860

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin

Adiponectin regulates albuminuria and podocyte function in mice

Inhibition of inducible nitric-oxide synthase by activators of AMP-activated protein kinase: a new mechanism of action of insulin-sensitizing drugs

Diet-induced insulin resistance in mice lacking adiponectin/ACRP30

Regulation of differentiation of vascular smooth muscle cells.

Developmental biology of the vascular smooth muscle cell: building a multilayered vessel wall.

Molecular and cellular phenotypes and their regulation in smooth muscle.

cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1).

Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells.

On the selectivity of superoxide dismutase mimetics and its importance in pharmacological studies.

P304

218-228

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/ME.2009-0128

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2009-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19889816

http://www.w3.org/2001/XMLSchema#string

P921

lipopolysaccharide

P932

5428142

http://www.w3.org/2001/XMLSchema#string